NCT04171752View on ClinicalTrials.gov

Elafibranor Pharmacokinetic Parameters in Elderly Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 22, 2019

Primary Completion Date

March 22, 2020

Study Completion Date

March 30, 2020

Conditions
GeriatricsHealthy
Interventions
DRUG

elafibranor

elafibranor 120mg is a coated tablet for oral administration

Trial Locations (1)

35042

BIOTRIAL, Rennes

Sponsors

Lead Sponsor

Genfit
All Listed Sponsors
lead

Genfit

INDUSTRY

NCT04171752 - Elafibranor Pharmacokinetic Parameters in Elderly Healthy Volunteers | Biotech Hunter | Biotech Hunter